LD-38
LD-38 is a drug-linker conjugate for ADC. LD-38 consists of a topoisomerase 1 inhibitor (Exatecan) and a highly hydrophilic stable and cleavable linker. LD-38 can be used for synthesis of ADC[1][2].
Product Specifications
CAS Number
3094583-35-1
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C(C=CC1=O)N1CCC(NCCOCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](C(NC2=CC=C(COC(N[C@H]3CCC(C(C)=C(F)C=C4N=C5C6=CC7=C8COC([C@](CC)7O)=O)=C4C3=C5CN6C8=O)=O)C=C2)=O)CCC(NCC[N+](C)(CCCS([O-])(=O)=O)C)=O)=O)=O)=O
Molecular Formula
C67H87FN10O20S
Molecular Weight
1403.53
References & Citations
[1]Wu G, et al. KA-3123-LD38: a novel bispecific antibody-drug conjugate (ADC) targeting EGFR and B7H3 with a DNA topoisomerase I inhibitor payload[J]. Cancer Research, 2025, 85 (8_Supplement_1) : 2132-2132.|[2]Catherine C, et al. An anti_itga2 antibody drug conjugate. WO2025153055A1. 2025-07-24.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Topo I
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880204-500 1x 500 µL
Complement C4d (C4D204), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880630-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942498-500 1x 500 µL
Bcl-6 (Follicular Lymphoma Marker) (rBCL6/1718), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942290-100 1x 100 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/2290R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details